- Home
- Applications
- europe
- diagnosis cancer
Show results for
Refine by
Diagnosis Cancer Product Applications In Europe
5 applications found
Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology to early detection and accurate prognosis. ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate ...
ByMDxHealth based in Irvine, CALIFORNIA (USA)
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. ...
ByOncoDiag based in Miserey, FRANCE
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. ...
ByAurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA)
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC ...
ByOncoDiag based in Miserey, FRANCE